Royal College of Surgeons in Ireland
Browse
MicroRNA Dysregulation in Cystic Fibrosis..pdf (1.27 MB)

MicroRNA Dysregulation in Cystic Fibrosis.

Download (1.27 MB)
Version 2 2022-03-03, 12:40
Version 1 2019-11-22, 16:34
journal contribution
posted on 2019-11-22, 16:34 authored by Paul J. McKiernan, Catherine M. Greene

The cystic fibrosis lung is a complex milieu comprising multiple factors that coordinate its physiology. MicroRNAs are regulatory factors involved in most biological processes and it is becoming increasingly clear that they play a key role in the development and manifestations of CF lung disease. These small noncoding RNAs act posttranscriptionally to inhibit protein production. Their involvement in the pathogenesis of CF lung disease stems from the fact that their expression is altered in vivo in the CF lung due to intrinsic and extrinsic factors; to date defective chloride ion conductance, endoplasmic reticulum stress, inflammation, and infection have been implicated in altering endogenous miRNA expression in this setting. Here, the current state-of-the-art and biological consequences of altered microRNA expression in cystic fibrosis are reviewed.

History

Comments

The original article is available at http://www.hindawi.com/

Published Citation

McKiernan PJ, Greene CM. MicroRNA Dysregulation in Cystic Fibrosis. Mediators of Inflammation. 2015;2015:529642.

Publication Date

2015-01-01

Publisher

Hindawi Publishing Corporation

PubMed ID

26185362